Bajaj Auto: To Outgrow The Industry
Bajaj Auto: To Outgrow The Industry
Bajaj Auto: To Outgrow The Industry
Bajaj Auto
To outgrow the industry
Sector: Auto Bajaj Auto Limited (BAL) is poised to continue outpacing the domestic
2W industry, driven by new product launches across segments (entry,
Company Update
mid and premium). Moreover, BAL would be the least impacted by
transition to BS6 emission norms given the higher share of premium
Change
motorcycles (40% of volumes) where price increase on account of
Reco: Buy á BS6 is 6-7% compared to 12-14% for the entry-level bikes. In addition,
CMP: Rs. 3,101 higher proportion of exports (45% of volumes), which is immune from
BS6 norm change and growing at a healthy rate of 7-8% would enable
Price Target: Rs. 3,575 á
outperformance by BAL. We expect mid-single digit volume growth
for BAL in FY2021 as against flat volumes expected for the industry.
á Upgrade No change â Downgrade
Earnings growth is expected to accelerate to 9% CAGR over FY2020-
FY2022 as against 3% earnings CAGR over FY2017-FY2019. Hence, we
Company details upgrade our recommendation on the stock to Buy from Hold earlier, as
we rollover our target multiple to FY2022 earnings. Our price target (PT)
Market cap: Rs. 89,740 cr
stands at Rs. 3,575. BAL is our preferred pick in the 2W space.
52-week high/low: Rs. 3,290/2,400 BAL to outgrow the 2W industry: BAL’s market share improved from 15.6%
in FY2018 to 18.8% in 9MFY2020, driven by new launches across segments
NSE volume: (No of
shares)
4.7 lakh viz. (entry, mid and premium). With planned new launches, management
is targeting to reach 24% market share over the next few years. Moreover,
BSE code: 532977 BAL would be least impacted by transition to BS6 norms, given the higher
proportion of premium motorcycles (40% of volumes), where price hike
NSE code: BAJAJ-AUTO is half compared to entry bikes and exports (45% of volumes), which are
immune to BS6 norms. Strong growth in exports, driven by healthy growth
Sharekhan code: BAJAJ-AUTO
in key markets and entry into new markets would also volumes. We expect
Free float: (No of mid-single digit volume growth for BAL in FY2021 as against flat volumes
13.45 cr for the industry.
shares)
Our Call
Shareholding (%) Earnings growth to accelerate; Upgrade to Buy: BAL is poised to outpace
Promoters 53.5% the industry’s growth, driven by new launches, minimal impact of BS6
transition and healthy growth in exports. We expect mid-single digit
Institutions 9.8% volume growth for BAL as against flat volumes expected for the industry.
Corporate Bodies 4.6% Earnings growth is expected to accelerate to 9% CAGR over FY2020-
FY2022 as compared to 3% growth over FY2017-FY2019. We rollover our
Foreign 14.5%
target multiple on FY2022 earnings and upgrade our recommendation to
Public and Others 17.6% Buy from Hold earlier. Our PT stands at Rs. 3,575 (earlier PT of Rs. 3,400).
Price chart
Key Risks
3400 Prolonged slowdown in the domestic market can impact the financials.
3200 Aggressive discounting adopted by 2W players can have an adverse
3000 impact on margins.
2800
Valuation Rs cr
2600
Particulars FY17 FY18 FY19 FY20E FY21E
2400 Net Sales 25,218.9 30,250.0 31,320.2 35,479.5 38,839.5
Jan-19
Jan-20
Jul-19
Sep-19
Nov-19
May-19
Mar-19
21
19
17
15
13
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Q1FY20
Q2FY20
Q3FY20
Source: SIAM, Company
40,000 20
15
30,000
10 Export, 45%
20,000
5
10,000 0 Domestic ,
55%
0 (5)
FY17 FY18 FY19 FY20E FY21E FY22E
6,000 6,000
20 15
5,000
5,000
4,000 15 10
4,000
3,000 10 5
3,000
2,000
5 2,000 0
1,000
0 0 1,000 (5)
FY17 FY18 FY19 FY20E FY21E FY22E FY17 FY18 FY19 FY20 FY21 FY22
EBITDA (Rs cr - LHS) OPM (% - RHS) PAT (Rs cr - LHS) Growth (% - RHS)
30.0
20.0
20.0
10.0
10.0
0.0 0.0
FY17 FY18 FY19 FY20E FY21E FY22E FY17 FY18 FY19 FY20E FY21E FY22E
25.0
20.0
15.0
10.0
5.0
0.0
Jun-08
Jun-09
Jun-10
Jun-11
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Jun-17
Jun-18
Jun-19
Dec-08
Dec-09
Dec-10
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
Dec-17
Dec-18
Dec-19
Forward P/E (x) Average P/E (x) Peak P/E (x) Trough P/E (x)
Peer valuation
CMP O/S P/E (x) EV/EBIDTA (x) P/BV (x) RoCE (%)
MCAP
Particulars (Rs / Shares
(Rs Cr) FY20E FY21E FY20E FY21E FY20E FY21E FY20E FY21E
Share) (Cr)
Bajaj Auto 3,101.0 28.93 89,740 18.3 17.0 9.6 8.0 3.3 3.0 18.1 17.9
Hero Motocorp 2,433.0 19.97 48,601 14.8 14.1 8.1 7.5 3.3 3.0 22.3 21.4
TVS Motors 489.0 47.51 23,313 23.0 19.2 11.0 9.4 5.1 4.3 22.1 22.5
Source: Company, Sharekhan Research
Investment theme
BAL is the market leader in the premium motorcycle segment and three-wheelers. BAL has strongly developed
its brand in key export markets and is currently India’s largest two-wheeler and three-wheeler exporter. BAL
is likely to outgrow the 2W industry given the minimal impact of transition from BS4 to BS6 norms due to
lower inventory levels, higher share of exports and premium motorcycles. BAL management has planned
new launches across segments and aims to increase its market from 19% currently to 24% over the next few
years. Healthy growth in export motorcycles should continue. We upgrade our recommendation to “Buy”
from “Hold” earlier.
Key Risks
BAL derives about 45% of volumes from export markets; hence, it is exposed to forex risks. Any adverse
currency movement in INR/USD can impact profitability.
Any adverse government policy for full switchover to electric vehicles in both the two-wheeler and three
wheeler segments would impact market positioning of the company.
Prolonged slowdown in domestic market can impact the financials
Additional Data
Key management personnel
Rahul Bajaj Chairman Executive
Rajiv Bajaj MD & CEO
Rakesh Sharma Executive Director
Soumen Ray CFO
Source: Company Website
Top 10 shareholders
Sr. No. Holder Name Holding (%)
1 Bajaj Holdings & Investment Ltd 33.43
2 Jamnalal Sons Pvt Ltd 8.95
3 Life Insurance Corp of India 4.6
4 Jaya Hind Industries Ltd 3.35
5 Maharashtra Scooters Ltd 2.34
6 Bajaj Sevashram Pvt Ltd 1.54
7 Norges Bank Investment Management 1.38
8 Government Pension Fund 1.38
9 Bachhraj & Co Pvt Ltd 1.26
10 SBI Funds Management 1.14
Source: Bloomberg
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a position in the companies mentioned in the article.
Disclaimer: This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity
to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation
and any review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice.
This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official
confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may
receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN
has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While
we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies,
their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also,
there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is
prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients
of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments
can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and
risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to
advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach
different conclusions from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any
locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession
this document may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the
views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or
their securities and do not necessarily reflect those of SHAREKHAN. The analyst further certifies that neither he or its associates
or his relatives has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of
the company at the end of the month immediately preceding the date of publication of the research report nor have any material
conflict of interest nor has served as officer, director or employee or engaged in market making activity of the company. Further, the
analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part
of the analyst’s compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this
document. Sharekhan Limited or its associates or analysts have not received any compensation for investment banking, merchant
banking, brokerage services or any compensation or other benefits from the subject company or from third party in the past twelve
months in connection with the research report.
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make
market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested
in any of the securities or related securities referred to in this report and they may have used the information set forth herein before
publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company
mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved
in, or related to, computing or compiling the information have any liability for any damages of any kind.
Compliance Officer: Mr. Joby John Meledan; Tel: 022-61150000; email id: compliance@sharekhan.com;
For any queries or grievances kindly email igc@sharekhan.com or contact: myaccount@sharekhan.com
Registered Office: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg
Railway Station, Kanjurmarg (East), Mumbai – 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos.: BSE
/ NSE / MSEI (CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-IN-DP-365-2018; PMS: INP000005786;
Mutual Fund: ARN 20669; Research Analyst: INH000006183;
Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com;
Investment in securities market are subject to market risks, read all the related documents carefully before investing.